佰金生命科学(01466.HK)11月27日举行董事会会议批准中期业绩
Core Viewpoint - Baijin Life Sciences (01466.HK) will hold a board meeting on November 27, 2025, to approve the unaudited interim results for the six months ending September 30, 2025, and to consider the payment of an interim dividend, if any [1] Group 1 - The board meeting is scheduled for November 27, 2025 [1] - The meeting will focus on approving the interim results for the six months ending September 30, 2025 [1] - The company will also consider the potential payment of an interim dividend [1]